Naratriptan
Title: Naratriptan
CAS Registry Number: 121679-13-8
CAS Name: N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide
Molecular Formula: C17H25N3O2S
Molecular Weight: 335.46
Percent Composition: C 60.87%, H 7.51%, N 12.53%, O 9.54%, S 9.56%
Literature References: Serotonin 5-HT1B/1D receptor agonist. Prepn: A. W. Oxford et al., EP 303507; eidem, US 4997841 (1989, 1991 both to Glaxo). Pharmacology and receptor binding study: H. E. Connor et al., Cephalalgia 17, 145 (1997). Determn in plasma and pharmacokinetics in rabbits: B. D. Duléry et al., J. Pharm. Biomed. Anal. 15, 1009 (1997). Clinical trial in migraine: H. Havanka et al., Clin. Ther. 22, 970 (2000).
Properties: Crystals from ethyl acetate, mp 170-171°.
Melting point: mp 170-171°
 
Derivative Type: Hydrochloride
CAS Registry Number: 143388-64-1
Manufacturers' Codes: GR-85548A
Trademarks: Amerge (GSK); Naramig (GSK)
Molecular Formula: C17H25N3O2S.HCl
Molecular Weight: 371.93
Percent Composition: C 54.90%, H 7.05%, N 11.30%, O 8.60%, S 8.62%, Cl 9.53%
Properties: Microcrystals, mp 237-239°.
Melting point: mp 237-239°
 
Therap-Cat: Antimigraine.
Keywords: Antimigraine; Serotonin Receptor Agonist.

Others monographs:
StrobilurinsPotassium BorotartrateHypoxanthineCadmium Nitrate
Cetylpyridinium ChlorideErythrosineColumbinMagnesium Silicide
Arsenic AcidSqualaneOcimeneCyazofamid
VellosimineCefpiromeLead Hydroxidep-Chlorobenzylpseudothiuronium Chloride
©2016 DrugLead US FDA&EMEA